What’s been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news.

AI holds immense promise in accelerating drug discovery and development—but the journey from data to therapeutic impact is far from straightforward. Despite revolutionary breakthroughs, challenges ...

Registered Office: Newfrith House, 21 Hyde Street, Winchester, Hampshire, SO23 7DR, United Kingdom. Tel: +44 (0)208 191 8810 Email: info@frontlinegenomics.com ...

Can AI turn data into drug candidates? Discover its role in drug discovery, from predictive biology to biomarkers data ...

Currently, Illumina is comfortably the largest gene-sequencing company. But how did Illumina manage to monopolise the gene-sequencing market?

This webinar will demonstrate how variant interpretation software can improve the accuracy and speed of variant interpretation using specific case studies.

It is now possible to sequence an entire genome in just one day, due to the advent of next generation sequencing (NGS).

Single-cell RNA sequencing (scRNA-seq) has become the most established and widely used technique within single-cell analysis. Spatial transcriptomics is quickly following in the footsteps of scRNA-seq ...

Advances in protein sequencing enable deeper insights and facilitate applications such as biomarker discovery and personalised medicine.

In this feature, we explore the evolution of omics and assess whether genomics research is a dwindling trade, or if we’re just beginning.

A new system that classifies genetic mutations that are likely treatable by a therapy that uses splice-switching antisense oligonucleotides (ASOs).